Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 160: | Line 160: | ||
* Scaly | * Scaly | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * 1 to > 10 cm | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Sun-exposed areas | |||
* Head (cheek and nose) | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Shiny white to red, translucent or opaque structureless areas | * Shiny white to red, translucent or opaque structureless areas | ||
Line 170: | Line 172: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sclerosing basal cell carcinoma ''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sclerosing basal cell carcinoma (morpheaform)''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Papule | |||
* Plaque | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Flesh-colored | |||
* Slightly erythematous | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Firm | |||
* Indurated | |||
* Indistinct borders | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Sun-exposed areas | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 19:12, 19 February 2019
Diseases | Skin examination | Diagnosis | Additional findings | ||||||
---|---|---|---|---|---|---|---|---|---|
Type | Color | Texture | Size | Distribution | Dermoscopic Findings | Histopathology | |||
Cutaneous squamous cell carcinoma | SCC in situ (Bowen's disease) |
|
|
|
|
|
|
|
|
Invasive squamous cell carcinoma |
|
|
|
|
|
|
|
| |
Keratoacanthoma |
|
|
|
|
|
|
|
| |
Merkel cell carcinoma |
|
|
|
|
|
|
|
| |
Basal cell carcinoma | Nodular basal cell carcinoma |
|
|
|
|
|
| ||
Superficial basal cell carcinoma |
|
|
|
|
|
|
|
||
Sclerosing basal cell carcinoma (morpheaform) |
|
|
|
|
|
||||
Prurigo nodules |
|
|
|
|
|
|
| ||
Common nevus |
|
|
|
|
|
||||
Blue nevus |
|
|
|
|
|
||||
Spitz nevus | Nonpigmented Spitz nevus |
|
|
|
|
|
| ||
Reed-like Spitz |
|
|
|
|
| ||||
Melanoma | Melanoma in situ (Lentigo Maligna) |
|
|
|
|
|
|
|
|
Lentigo maligna melanoma |
|
|
|
|
|
|
|
| |
Superficial spreading melanoma |
|
|
|
|
|
|
| ||
Nodular melanoma |
|
|
|
|
| ||||
Acral lentiginous melanoma |
|
|
|
|
|
| |||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | Red, nonspecific lesion with slightly elevated borders |
| |||||
Solar lentigo |
|
|
|
|
|
| |||
Sebaceous hyperplasia |
|
|
|
|
|
|
| ||
Lichen planus-like keratosis |
|
|
|
|
|||||
Seborrheic keratosis |
|
||||||||
Actinic keratosis | less pigmentation, and tend to be somewhat smaller in size. | Erythema | Hyperkeratosis | painful |
SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia.